SCHEMBL23970518

SCHEMBL23970518

Cc1ccc(C(=O)OC(C)(C)C)c(CCCCCO)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.39
CYP4F2 P78329 3/20 0.36
CYP4A11 Q02928 3/20 0.36
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159250 1.00 TDP1 (0.39) TDP1CYP4F2CYP4A11ALDH1A1KDM4E
SCHEMBL23970627 0.88 TDP1 (0.38) TDP1CYP4F2CYP4A11GABRPGABRD
SCHEMBL30850136 0.88 TDP1 (0.38) TDP1CYP4F2CYP4A11GABRPGABRD
SCHEMBL23971334 0.84 TDP1 (0.37) TDP1CYP4F2CYP4A11GABRPGABRD
SCHEMBL30158968 0.79 PSMD10 (0.39) ALDH1A1PPARGPPARDPPARA
SCHEMBL23970525 0.75 RXRA (0.38) TDP1ALDH1A1KDM4ENR1H2RXRA
SCHEMBL30850115 0.75 NR1H2 (0.33) TDP1CYP4F2CYP4A11NR1H2RXRA
SCHEMBL23970754 0.74 TDP1 (0.36) TDP1CYP4F2CYP4A11ALDH1A1KDM4E
SCHEMBL23970756 0.74 TDP1 (0.36) TDP1CYP4F2CYP4A11ALDH1A1KDM4E
SCHEMBL30159052 0.74 TDP1 (0.36) TDP1CYP4F2CYP4A11ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 TDP1 199/4885CYP4F2 2632/4885CYP4A11 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.